Behcet's disease: Evaluation of a new instrument to measure clinical activity

Rheumatology

Volumn 38, Issue 8, 1999, Pages 728-733

  Bhakta, B B ^a   Brennan, P ^b   James, T E ^c   Chamberlain, M A ^a   Noble, B A ^d   Silman, A J ^b  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Activity; Behcet's disease; Measurement; Reliability

Indexed keywords

ARTHRITIS; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CORRELATION FUNCTION; DIARRHEA; DISEASE ACTIVITY; ERYTHEMA NODOSUM; EYE DISEASE; FATIGUE; GASTROINTESTINAL SYMPTOM; GENITAL ULCER; HEADACHE; HUMAN; MOUTH ULCER; PHYSICIAN; PRIORITY JOURNAL; PUSTULE; RELIABILITY; SCORING SYSTEM; HOSPITALIZATION; OBSERVER VARIATION; QUESTIONNAIRE;

BEHCET SYNDROME; HUMANS; OBSERVER VARIATION; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 0033175977     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.8.728     Document Type: Article

References (14)

1. International Study Group for Behçet's Disease. Evaluation of diagnostic (classification) criteria in Behçet's Disease - towards internationally agreed criteria. Br J Rheumatol 1992;31:299-308.
2. Chamberlain MA, Noble BA, Behçet's U.K. Study Group. Disease activity in Behçet's Disease. In: O'Duffy JD, Kokmen E, eds. Behçet's Disease, basic and clinical aspects. New York: Marcel Dekker, 1991:299-302.
3. Bhakta B, Hamuryudan V, Brennan P, Chamberlain MA, Barnes C, Silman AJ. Assessment of disease activity in Behçet's disease. In: Wechsler B, Godeau P, eds. Excerpta Medica Int Congress Series 1037, 611. Amsterdam: Elsevier Science Publishers BV, 1993:235-40.
4. Davatchi F, Akbaran M, Shahram F et al. Iran Behçet's Disease Dynamic Activity Measure. Hung Rheumatol 1991;32(suppl.):FP10-100 (Abstracts of the XIIth European Congress of Rheumatology).
5. Muftuoglu AU, Yazici H, Yurdakul S et al. Behçet's disease. Relation of serum C-reactive protein and erythrocyte sedimentation rates to disease activity. Int J Dermatol 1986;25:235-39.
6. Symmons DP, Coppock JS, Bacon PA et al. Development and assessment of a computerised index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG). Q J Med 1988;69:927-37.
7. Gladman DD, Goldsmith CH, Urowitz MB et al. Crosscultural validation and reliability of 3 disease activity indices in systemic lupus erythematosus. J Rheumatol 1992;19:608-11.
8. Liang MH, Socher SA, Larson MG, Schur PH. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
9. O'Neill T, Rigby AS, McHugh S, Silman AJ, Barnes CG on behalf of the International Study Group for Behçet's disease. Regional differences in clinical manifestations of Behçet's Disease. In: Wechsler B, Godeau P, eds. Excerpta Medica Int Congress Series 1037, 611. Amsterdam: Elsevier Science Publishers BV, 1993:159-63.
10. Wechsler B, Dell'Isola B, Vidailhet M et al. MRI in 31 patients with Behçet's disease and neurological involvement: prospective study with clinical correlation. J Neurol Neurosurg Psychiatry 1993;56:793-8.
11. Morrissey SP, Miller DH, Hermaszewski R et al. Magnetic resonance imaging of the central nervous system in Behçet's disease. Eur Neurol 1993;33:287-93.
12. Besana C, Comi G, Del Maschio A et al. Electrophysiological and MRI evaluation of neurological involvement in Behçet's disease. J Neurol Neurosurg Psychiatry 1989;52:749-54.
13. Dilsen N, Konice M, Aral O, Inanc M, Gul A, Ocal L. Important implications of skin pathergy test in Behçet's Disease. In: Wechsler B, Godeau P, eds. Excerpta Medica Int Congress Series 1037, 611. Amsterdam: Elsevier Science Publishers BV, 1993:229-33.
14. Revuz J, Guillaume J, Janier M et al. Crossover study of thalidomide verses placebo in severe recurrent aphthous ulceration. Arch Dermatol 1990;126:923-7.